The International Society of Atopic Dermatitis (ISAD) is committed to advancing our understanding and treatment of atopic dermatitis through a variety of research initiatives, fellowships, and awards. These efforts aim to foster collaboration among researchers, encourage innovative studies, and ultimately improve patient care.
Research Activities
ISAD supports research across a broad spectrum of areas related to atopic dermatitis. This includes investigating the underlying causes of the disease, exploring new treatment approaches, and improving our understanding of the patient experience. While the specific research projects vary, they often focus on areas like genetics, immunology, skin barrier function, and the role of environmental factors. ISAD facilitates these activities through various mechanisms, including fostering collaborative research networks and disseminating research findings through publications and conferences.
Fellowships
ISAD offers fellowships to promising researchers, providing them with opportunities to develop their skills and contribute to the field. These fellowships often support early-career investigators, allowing them to gain valuable experience in conducting research under the mentorship of established experts. The ISAD-GADA Fellowship, for example, is one such opportunity aimed at fostering international collaboration and advancing research in atopic dermatitis. These fellowships play a crucial role in nurturing the next generation of atopic dermatitis researchers.
Rajka Medal and Prize
The Georg Rajka Medal and Prize is a prestigious award presented by ISAD to recognize outstanding contributions to the field of atopic dermatitis. It honors individuals who have made significant advancements in research, clinical care, or education related to the disease. This award acknowledges the impact of their work and serves as an inspiration for others to strive for excellence in the field. It highlights the importance of continued innovation and dedication in the fight against atopic dermatitis.